Released May 10, 2022 | KOFU, JAPAN
en
Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info is tracking seven projects in Japan's Pharmaceutical & Biotech Industry that are related to research and development (R&D), totaling more than US$364 million in investment value.
Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of related project reports.
The projects include Chugai Pharmaceutical Company Limited's Biopharmaceutical R&D Center in Yokohama. Now under construction, the center is planned for completion in 2023.
Industrial Info Resources (IIR) is the world's leading provider of market intelligence across the upstream, midstream and downstream energy markets and all other major industrial markets. IIR's Global Market Intelligence Platform (GMI) supports our end-users across their core businesses, and helps them connect trends across multiple markets with access to real, qualified and validated project opportunities. Follow IIR on: LinkedIn.
Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of related project reports.
The projects include Chugai Pharmaceutical Company Limited's Biopharmaceutical R&D Center in Yokohama. Now under construction, the center is planned for completion in 2023.
Industrial Info Resources (IIR) is the world's leading provider of market intelligence across the upstream, midstream and downstream energy markets and all other major industrial markets. IIR's Global Market Intelligence Platform (GMI) supports our end-users across their core businesses, and helps them connect trends across multiple markets with access to real, qualified and validated project opportunities. Follow IIR on: LinkedIn.
